NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: LSB Industries Inc. (NYSE: LXU), Continental Building Products Inc. (NYSE: CBPX), Energy Recovery Inc. (NASDAQ: ERII) and Marine Products Corp (NYSE: MPX). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

LXU Research Package: http://www.traders-choice.com/pdf?s=LXU

CBPX Research Package: http://www.traders-choice.com/pdf?s=CBPX

ERII Research Package: http://www.traders-choice.com/pdf?s=ERII

MPX Research Package: http://www.traders-choice.com/pdf?s=MPX

============

Highlights from today’s reports include:

On Wednesday, December 24, 2015, Nasdaq Composite ended at 5,048.49, up 0.05%, Dow Jones Industrial Average declined 0.29%, to finish the day at 17,552.17, and the S&P 500 closed at 2,060.99, down 0.16%.

– The stock of LSB Industries Inc. gained 1.42% to close Thursday’s session at USD 7.85. The shares of the company moved in the range of USD 7.56 and USD 7.92. A trading volume of 0.33 million shares was recorded, which was lower than its 150-day daily average volume of 0.42 million shares and marginally above its 52-week average volume of 0.32 million shares. Over the last five days LSB Industries Inc.’s shares have advanced 26.41% and in the past one month the stock has gained a momentum of 22.85%. However, over the last three months the stock has declined 57.61% and in the past six months the shares have registered a loss of 81.71%. The company has returned 22.27% in the past one month, on a compounded total return basis. Further, the stock is trading at a price to book ratio of 0.43, which compares to a historical PB ratio near to 1.64. Further, the stock is trading at a price to cash flow ratio of 3.72 and price to sales ratio of 0.25.

– Continental Building Products Inc.’s stock increased by 2.86% to close Thursday’s session at USD 17.61. The company’s shares fluctuated in the range of USD 17.02 and USD 17.75. A total of 0.12 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.43 million shares and its 52-week average volume of 0.35 million shares. Over the last three days Continental Building Products Inc.’s shares have advanced 2.03% and in the past one week the stock has moved up 3.83%. However, over the last three months the stock has lost 17.98% and in the past six months the shares have shed 23.40%. Further, the company is trading at a price to sales ratio of 1.67 and price to book ratio of 2.42. The stock has a Relative Strength Index of 49.48.

– Energy Recovery Inc.’s stock edged higher by 0.70% to close Thursday’s session at USD 7.15. The company’s shares oscillated between USD 7.08 and USD 7.21. The stock recorded a trading volume of 0.05 million shares, which was below its 50-day daily average volume of 1.45 million shares and its 52-week average volume of 0.47 million shares. Over the last three days Energy Recovery Inc.’s shares have remained flat and in the past one week the stock has moved down 4.16%. Furthermore, over the last three months the stock has gained 212.23% and in the past six months the shares have picked up 151.76%. On a compounded total return basis, the company has returned 1.71% in the past one month. Further, the company is trading at a price to book ratio of 5.97, which compares to a historical PB ratio near to 3.91. Additionally, the stock is trading at a price to sales ratio of 8.58.

– The stock of Marine Products Corp gained 1.66% to close Thursday’s session at USD 6.14. The shares of the company moved in the range of USD 6.03 and USD 6.22. A trading volume of 0.01 million shares was recorded, which was lower than its 150-day daily average volume of 0.02 million shares. Over the last five days Marine Products Corp’s shares have advanced 1.82% while in the past one month the stock has lost 8.63%. Additionally, over the last three months the stock has declined 8.12% and in the past six months the shares have registered a loss of 4.72%. Marine Products Corp has a current dividend yield of 2.61%. Further, the company is trading at a price to book ratio of 2.59, which compares to a historical PB ratio near to 3.83. Further, the stock is trading at a price to cash flow ratio of 15.23 and price to sales ratio of 1.18.

—

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 435153

NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Trader’s Choice has initiated research coverage on WMI Holdings Corp (NASDAQ: WMIH). Select highlights from the internally released reports are being made available to the general public (included below), with access to the entirety of the research available to new members.

Today, membership is open to readers on a complementary basis at the following URL:

http://www.traders-choice.com/pdf?s=WMIH

Highlights from our WMIH Report include:

Adequate Funding Arrangement for Future Acquisitions – With its legacy reinsurance business being operated in runoff mode, WMIH continues its engagement in the development of strategies to acquire one or more of an operating business, to grow its business further. WMIH’s primary focus in 2015 was to identify and evaluate acquisition opportunities of varying sizes in the financial services industry, which included targets within consumer finance, specialty finance, leasing and insurance operations.

Advantages of Recent NASDAQ Listing – The stock of WMIH commenced its trading on NASDAQ Capital Market on Monday, September 28, 2015, under the symbol “WMIH.” Prior to this, the shares of WMIH were traded on the OTCQB® Venture Market operated by OTC Markets Group. As benefits of its recent listing on one of the largest U.S. stock exchanges, the company’s shares are likely to receive more visibility among institutional and retail investors in NASDAQ.

Strategic Benefits from KKR’s Nominations – WMIH reincorporation from the State of Washington to the State of Delaware resulted in the expansion of the size of its Board of Directors from seven to eleven members. Consequently, Tagar C. Olson and Paul E. Raether, who were nominated by KKR Fund Holdings L.P. (KKR Fund), pursuant to the Investor Rights Agreement between the company and KKR Fund, joined the board of WMIH along with William C. Gallagher and Thomas L. Fairfield, effective as of May 12, 2015.

Q3 2015 Results Highlights – On December 15, 2015, WMIH Corp came out with it Q3 2015 results. Net revenue totaled $1.49 million, a 13.54% decline from the year-ago period, while general and administrative expenses (G&A) grew considerably to $13.20 million, reflecting a 926.0% year-over-year increase. WMIH’s net operating loss widened substantially to $12.72 million, compared to a net operating loss of $1.30 million in Q3 2014.

Overall Outlook for the Reinsurance Industry – The outlook for the global reinsurance sector remains negative according to a report by Moody’s Investors Services. Moody’s expects excess capital in the reinsurance market and weaker demand from primary insurers.

To find out how this influences our rating on WMI Holdings Corp, read the full report in its entirety here: http://www.traders-choice.com/pdf?s=WMIH.

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 435152

NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: Horsehead Holding Corp. (NASDAQ: ZINC), Performance Sports Group Ltd. (NYSE: PSG), Dynamic Materials Corp. (NASDAQ: BOOM) and U.S. Global Investors Inc. (NASDAQ: GROW). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

ZINC Research Package: http://www.traders-choice.com/pdf?s=ZINC

PSG Research Package: http://www.traders-choice.com/pdf?s=PSG

BOOM Research Package: http://www.traders-choice.com/pdf?s=BOOM

GROW Research Package: http://www.traders-choice.com/pdf?s=GROW

============

Highlights from today’s reports include:

On Thursday, December 24, 2015, Nasdaq Composite ended at 5,048.49, up 0.05%, Dow Jones Industrial Average declined 0.29%, to finish the day at 17,552.17, and the S&P 500 closed at 2,060.99, down 0.16%.

– Horsehead Holding Corp.’s stock increased by 1.42% to close Thursday’s session at USD 2.15. The company’s shares fluctuated in the range of USD 2.12 and USD 2.28. A total of 0.89 million shares exchanged hands, which was lesser than its 50-day daily average volume of 1.75 million shares and its 52-week average volume of 1.18 million shares. Over the last three days Horsehead Holding Corp.’s shares have advanced 32.72% and in the past one week the stock has moved up 27.22%. However, over the last three months the stock has lost 49.65% and in the past six months the shares have shed 82.68%. Further, the shares are trading at a price to book ratio of 0.26 compared to a historical PB ratio of 1.87. Additionally, the stock is trading at a price to sales ratio of 0.28. Moreover, Horsehead Holding Corp. is trading below its 50-day moving average of USD 2.27.

– Performance Sports Group Ltd.’s stock advanced 0.60% to close Thursday’s session at USD 10.01. The share price vacillated between USD 9.77 and USD 10.02. The stock recorded a trading volume of 0.15 million shares, which was close to its 50-day daily average volume of 0.16 million shares and below its 52-week average volume of 0.25 million shares. Over the last three days Performance Sports Group Ltd.’s shares have advanced 2.56% and in the past one week the stock has moved up 2.14%. However, in the last six months the stock has lost 40.49% and year to date the shares have shed 44.36%. Further, the stock is trading at a price to book (MRQ) ratio of 1.48 and a price to sales (TTM) ratio of 0.72. Additionally, Performance Sports Group Ltd. is trading below its 50-day moving average of USD 10.89.

– Dynamic Materials Corp.’s stock increased by 2.28% to close Thursday’s session at USD 6.72. The company’s shares fluctuated in the range of USD 6.52 and USD 6.83. A total of 0.06 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.09 million shares and its 52-week average volume of 0.11 million shares. Over the last three days Dynamic Materials Corp’s shares have advanced 5.99% and in the past one week the stock has moved up 9.09%. However, over the last three months the stock has lost 22.40% and in the past six months the shares have shed 38.46%. Dynamic Materials Corp has a current dividend yield of 1.19%. Further, the shares are trading at a price to book ratio of 0.67 compared to a historical PB ratio of 1.45. Additionally, the stock is trading at a price to cash flow ratio of 7.24 and price to sales ratio of 0.54.

– U.S. Global Investors Inc.’s stock slipped by 0.78% to close Thursday’s session at USD 1.28. The company’s shares oscillated between USD 1.21 and USD 1.30. The stock recorded a trading volume of 0.02 million shares, which was below its 50-day daily average volume of 0.05 million shares and at par with its 52-week average volume of 0.02 million shares. Over the last one week U.S. Global Investors Inc.’s shares have advanced 11.30% and in the past one month the stock has gained a momentum of 13.27%. However, over the last three months the stock has lost 32.63% and year to date the shares have shed 57.02%. U.S. Global Investors Inc. has a current dividend yield of 2.34%. Further, the shares are trading at a price to book ratio of 0.74 compared to a historical PB ratio of 1.50. Additionally, the stock is trading at a price to sales ratio of 2.02. Moreover, the stock is trading close to its 50-day moving average of USD 1.27 but below its 200-day moving average of USD 1.91.

—

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 435151

NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: Unisys Corp. (NYSE: UIS), Central Garden & Pet Co. (NASDAQ: CENTA), Evolent Health Inc. (NYSE: EVH) and Crawford & Co. (NYSE: CRD.B). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

UIS Research Package: http://www.traders-choice.com/pdf?s=UIS

CENTA Research Package: http://www.traders-choice.com/pdf?s=CENTA

EVH Research Package: http://www.traders-choice.com/pdf?s=EVH

CRD.B Research Package: http://www.traders-choice.com/pdf?s=CRD.B

============

Highlights from today’s reports include:

On Thursday, December 24, 2015, Nasdaq Composite ended at 5,048.49, up 0.05%, Dow Jones Industrial Average declined 0.29%, to finish the day at 17,552.17, and the S&P 500 closed at 2,060.99, down 0.16%.

– Unisys Corp.’s stock added 0.92% to close Thursday’s session at USD 10.92. The company’s shares oscillated between USD 10.76 and USD 11.08 in trade during the day. The stock recorded a trading volume of 0.293 million shares, which was below its 50-day daily average volume of 0.439 million shares and its 52-week average volume of 0.443 million shares. Over the last five days Unisys Corp.’s shares have declined by 3.19% and in the past one month the stock has lost 11.65%. In addition, over the last three months the stock has lost 15.02% and year to date the shares have shed 62.96%. Further, the stock of the company is trading at a price to cash flow ratio of 4.43 and price to sales ratio of 0.17. Additionally, the shares have a Relative Strength Index of 38.13.

– Central Garden & Pet Co.’s stock declined 6.06% to close Thursday’s session at USD 13.65. The share price vacillated between USD 13.61 and USD 14.47 in trade during the day. The stock recorded a trading volume of 0.10 million shares, which was below its 50-day daily average volume of 0.16 million shares and its 52-week average volume of 0.21 million shares. Over the last three days Central Garden & Pet Co.’s shares have declined by 2.22% and in the past one week the stock has moved down 4.81%. However, in the last six months the stock has gained 25.82% and year to date the shares have picked up 42.93%. Further, the stock is trading at a price to book ratio of 1.40 which compares to a historical PB ratio close to 1.62. Additionally, the shares are trading at a price to cash flow ratio of 1.70 and price to sales ratio of 0.10.

– Evolent Health Inc.’s stock increased by 2.14% to close Thursday’s session at USD 13.35. The company’s shares fluctuated in the range of USD 12.94 and USD 13.41 during the day. A total of 0.03 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.14 million shares and was also below its 52-week average volume of 0.29 million shares. Over the last three days Evolent Health Inc.’s shares have advanced 3.17% and in the past one week the stock has moved up 10.60%. However, over the last three months the stock has lost 25.13% and in the past six months the shares have shed 28.61%. Further, the shares of the company are trading at a price to book ratio of 0.86 while the stock has a Relative Strength Index of 43.30.

– The shares of Crawford & Co.’s (B-shares) slipped by 1.24% to close Thursday’s session at USD 5.58. The stock oscillated between USD 5.55 and USD 5.61 in trade during the day. The stock recorded a trading volume of 0.005 million shares, which was below its 50-day daily average volume of 0.031 million shares and its 52-week average volume of 0.032 million shares. Over the last five days Crawford & Co.’s shares have declined by 1.24% and in the past one month the stock has lost 0.36%. In addition, over the last three months the stock has lost 10.58% and year to date the shares have shed 43.77%. Crawford & Co has a current dividend yield of 3.58%. Further, the stock is trading at a price to book ratio of 1.88 which compares to a historical PB ratio close to 3.28. Additionally, the shares are trading at a price to cash flow ratio of 1.97 and price to sales ratio of 0.11.

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 435150

NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Moments ago, Trader’s Choice released new research updates concerning several important developing situations including the following equities: ArcelorMittal SA (NYSE: MT), Epizyme Inc. (NASDAQ: EPZM), NII Holdings Inc. (NASDAQ: NIHD) and DRDGOLD Ltd. (NYSE: DRD). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

MT Research Package: http://www.traders-choice.com/pdf?s=MT

EPZM Research Package: http://www.traders-choice.com/pdf?s=EPZM

NIHD Research Package: http://www.traders-choice.com/pdf?s=NIHD

DRD Research Package: http://www.traders-choice.com/pdf?s=DRD

============

Highlights from today’s reports include:

On Thursday, December 24, 2015, Nasdaq Composite ended at 5,048.49, up 0.05%, Dow Jones Industrial Average declined 0.29%, to finish the day at 17,552.17, and the S&P 500 closed at 2,060.99, down 0.16%.

– ArcelorMittal SA’s stock advanced 1.77% to close Thursday’s session at USD 4.61. The share price vacillated between USD 4.50 and USD 4.62 in trade during the day. The stock recorded a trading volume of 2.35 million shares, which was below its 50-day daily average volume of 9.56 million shares and its 52-week average volume of 7.96 million shares. Over the last three days ArcelorMittal SA’s shares have advanced 18.81% and in the past one week the stock has moved up 23.59%. However, in the last six months the stock has lost 55.63% and year to date the shares have shed 56.39%. ArcelorMittal SA has a current dividend yield of 4.34%. Further, the shares are trading at a price to sales ratio of 0.11 and a price to book ratio of 0.25.

– The stock of Epizyme Inc. lost 0.71% to close Thursday’s session at USD 16.84. The shares of the company moved in the range of USD 16.80 and USD 17.78 during the day. A trading volume of 0.23 million shares was recorded, which was lower than its 150-day daily average volume of 0.48 million shares and was also below its 52-week average volume of 0.43 million shares. Over the last five days Epizyme Inc.’s shares have advanced 7.81% and in the past one month the stock has gained a momentum of 13.63%. However, over the last three months the stock has declined 14.13% and in the past six months the shares have registered a loss of 23.97%. Further, the stock is trading at a price to book ratio of 3.73 while the historical PB ratio is close to 4.05. Additionally, the shares are trading at a price to sales ratio of 57.25.

– NII Holdings Inc.’s stock increased by 0.41% to close Thursday’s session at USD 4.90. The company’s shares fluctuated in the range of USD 4.85 and USD 4.99 during the day. A total of 0.09 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.27 million shares and was also below its 52-week average volume of 0.35 million shares. Over the last three days NII Holdings Inc.’s shares have declined by 1.61% and in the past one week the stock has moved down 0.81%. Furthermore, over the last three months the stock has lost 43.55%. The shares of the company are trading at a price to sales ratio of 0.27 and a price to book ratio of 0.30. Additionally, the stock has a Relative Strength Index of 28.95.

– DRDGOLD Ltd.’s stock edged higher by 0.65% to close Thursday’s session at USD 1.56. The company’s shares oscillated between USD 1.52 and USD 1.60 in trade during the day. The stock recorded a trading volume of 0.03 million shares, which was below its 50-day daily average volume of 0.06 million shares and its 52-week average volume of 0.12 million shares. Over the last three days DRDGOLD Ltd.’s shares have advanced 5.41% and in the past one week the shares have moved up 6.12%. Furthermore, over the last three months the stock has gained 22.83% while in the past six months the shares have shed 17.89%. DRDGOLD Ltd has a current dividend yield of 5.94%. Further, the shares of the company are trading at a price to sales ratio of 0.51 and a price to book ratio of 0.66.

About Trader’s Choice:

Trader’s Choice (“TC”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com

SOURCE: Trader’s Choice

ReleaseID: 435149

SCOTTSDALE, AZ / ACCESSWIRE / December 28, 2015 / Zoned Properties, Inc. (OTCQX: ZDPY) a strategic real estate development firm whose primary mission is to identify, develop, and manage sophisticated, safe, and sustainable properties in emerging industries, including the licensed medical marijuana industry, today announced that the company’s stock has been approved to trade on the OTCQX(R) Best Market. The company’s common stock previously traded on the Pink market.

OTCQX is designed for established, investor-focused U.S. and international companies that have met high financial standards, are current in their financial reporting and have been sponsored by a professional third-party advisor. The OTCQX market is considered by the SEC as an “established public market” for the purpose of determining the public market price when registering securities for resale in equity line financings with the SEC. The Pink market is not considered an “established public market” by the SEC and many broker-dealers have restrictions around trading or recommending Pink stocks to investors. Trading on OTCQX indicates that a company is committed to providing a transparent market for its investors and maintaining high financial and operating standards.

Bryan McLaren, Chief Executive Officer of Zoned Properties, stated, “Moving to the OTCQX market is a milestone in the development of our company as we establish ourselves as a fully-reporting entity, committed to providing timely and accurate financial information to shareholders and prospective investors. It is a major step towards increasing the liquidity of our stock and reaching a larger number of investors and more readily enables the execution of orders for our company’s stock.”

About Zoned Properties, Inc. (OTCQX: ZDPY):

Zoned Properties, Inc. is a strategic real estate development firm whose primary mission is to identify, develop, and manage sophisticated, safe, and sustainable properties in emerging industries. The Company acquires commercial properties that face unique zoning challenges and identifies solutions that can potentially have a major impact on the cash flow and value generated. Zoned Properties, Inc. targets commercial properties that can be acquired and potentially re-zoned for specific purposes. Zoned Properties does not grow, harvest, sell or distribute cannabis or any substances regulated under United States law such as the controlled substances act.

Safe Harbor Statement:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in the Company’s preliminary prospectus dated November 25, 2015, as updated from time to time in our filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact:

Investor Relations
Brett Maas
Managing Partner
Hayden IR
Tel (646) 536-7331
brett@haydenir.com

SOURCE: Zoned Properties, Inc.

ReleaseID: 435132

NEW YORK, NY / ACCESSWIRE / December 28, 2015 / Park Lane Advisor has initiated coverage on the following equities: Agenus Inc. (NASDAQ: AGEN), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Arrowhead Research Corporation (NASDAQ: ARWR), and Infinity Pharmaceuticals Inc. (NASDAQ: INFI). Free research report on Agenus can be accessed at http://www.parklaneadvisor.com/ On Thursday, December 24, 2015, the NASDAQ Composite ended at 5,048.49, up 0.05%, the Dow Jones Industrial Average edged 0.29% lower, to finish the day at 17,552.17, and the S&P 500 closed at 2,060.99, down 0.16%. The losses were broad based as six out of nine sectors ended the session in negative. Register for your complimentary reports at the links given below.

Agenus Inc.’s stock finished Thursday’s session 6.22% higher at $4.78. A total of 0.90 million shares were traded, which was below its three months average volume of 1.37 million shares. Over the last one month and the previous three months, Agenus Inc.’s shares have fallen by 0.42% and 5.16%, respectively. However, the stock has surged 20.40% since the beginning of 2015. The company’s shares are trading above their 50-day moving average by 2.88%. Agenus Inc.’s stock has a Relative Strength Index (RSI) of 56.28. Sign up and read the free notes on AGEN at:

http://www.parklaneadvisor.com/

On Thursday, shares in Progenics Pharmaceuticals Inc. ended the session 4.05% higher at $6.42. The stock reported a trading volume of 0.56 million shares, below its three months average volume of 1.02 million shares. Progenics Pharmaceuticals Inc.’s shares have declined 3.89% in the last one month, 0.62% in the previous three months and 15.08% on YTD basis. The company is trading 4.92% below its 50-day moving average and 4.64% below its 200-day moving average. Moreover, shares of Progenics Pharmaceuticals Inc. have an RSI of 51.36. The complimentary notes on PGNX can be downloaded in PDF format at:

http://www.parklaneadvisor.com/

Arrowhead Research Corp.’s stock advanced 1.97%, to close the day at $6.20. The stock recorded a trading volume of 0.34 million shares, much below its three months average volume of 1.68 million shares. Arrowhead Research Corp.’s shares have lost 14.60% in the previous three months and 15.99% since the start of this year. However, the stock has gained 7.08% in the last one month. The company’s shares are trading 10.63% above their 50-day moving average. Additionally, Arrowhead Research Corp. has an RSI of 58.54. Register for free on Park Lane Advisor and access the latest research on ARWR at:

http://www.parklaneadvisor.com/

On Thursday, shares in Infinity Pharmaceuticals Inc. recorded a trading volume of 0.26 million shares, lower than their three months average volume of 1.02 million shares. The stock ended the day 1.76% lower at $7.81. Infinity Pharmaceuticals Inc.’s stock has lost 6.13% in the last one month, 6.80% in the previous three months and 53.76% on YTD basis. The company is trading below its 50-day and 200-day moving averages by 10.76% and 26.45%, respectively. Furthermore, shares of Infinity Pharmaceuticals Inc. have an RSI of 42.32. The complete research on INFI is available for free at:

http://www.parklaneadvisor.com/

—

About Park Lane Advisor:

Park Lane Advisor (“PLA”) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. PLA has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PLA has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY:

PLA, the Author, the Reviewer and the Sponsor (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING:

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PLA nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.ParkLaneAdvisor.com

RESTRICTIONS:

PLA is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT:

For any questions, inquiries, or comments reach out to us directly at:

E-mail: media (at) ParkLaneAdvisor (dot) com

SOURCE: Park Lane Advisor

ReleaseID: 435133